カテゴリー： LP Information, 世界, 医療/バイオ

世界の凍結乾燥薬再構成用SWFI市場予測 2021年-2026年

【英語タイトル】Global SWFI for Reconstitution of Lyophilized Drugs Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9667）・商品コード：LPI21MY9667
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：164
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「凍結乾燥薬再構成用SWFIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バイアル、プレフィルドシリンジなど、用途別には、病院、診療所、その他などにセグメント区分してまとめました。凍結乾燥薬再構成用SWFIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・凍結乾燥薬再構成用SWFIの世界市場概要（サマリー）
・凍結乾燥薬再構成用SWFIの企業別販売量・売上
・凍結乾燥薬再構成用SWFIの企業別市場シェア
・凍結乾燥薬再構成用SWFIの世界市場規模 2016年-2021年：種類別（バイアル、プレフィルドシリンジ）
・凍結乾燥薬再構成用SWFIの世界市場規模 2016年-2021年：用途別（病院、診療所、その他）
・凍結乾燥薬再構成用SWFIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・凍結乾燥薬再構成用SWFIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・凍結乾燥薬再構成用SWFIのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・凍結乾燥薬再構成用SWFIの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・凍結乾燥薬再構成用SWFI市場の成長要因・課題・動向
・凍結乾燥薬再構成用SWFIの世界市場予測 2021年-2026年
・凍結乾燥薬再構成用SWFIの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・凍結乾燥薬再構成用SWFIのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・凍結乾燥薬再構成用SWFIのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・凍結乾燥薬再構成用SWFIの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・凍結乾燥薬再構成用SWFIの世界市場予測：種類別（バイアル、プレフィルドシリンジ）
・凍結乾燥薬再構成用SWFIの世界市場予測：用途別（病院、診療所、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of SWFI for Reconstitution of Lyophilized Drugs will have significant change from previous year. By the most conservative estimates of global SWFI for Reconstitution of Lyophilized Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the SWFI for Reconstitution of Lyophilized Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of SWFI for Reconstitution of Lyophilized Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by container: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Vials
Pre-filled Syringes

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer(Hospira)
B. Braun Medical Inc.
Baxter Corporation
Hikma
Fresenius Kabi
China Otsuka
Kelun
Shijiazhuang No. 4 Pharmaceutical
Deo Gratias Parenteral
Shapuaisi Pharma
Zhuhai Tongyuan Pharmaceutical
Shandong Qidu Pharma Group
Huaren

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Consumption 2016-2026
2.1.2 SWFI for Reconstitution of Lyophilized Drugs Consumption CAGR by Region
2.2 SWFI for Reconstitution of Lyophilized Drugs Segment by Container
2.2.1 Vials
2.2.2 Pre-filled Syringes
2.3 SWFI for Reconstitution of Lyophilized Drugs Sales by Container
2.3.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2016-2021)
2.3.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue and Market Share by Container (2016-2021)
2.3.3 Global SWFI for Reconstitution of Lyophilized Drugs Sale Price by Container (2016-2021)
2.4 SWFI for Reconstitution of Lyophilized Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 SWFI for Reconstitution of Lyophilized Drugs Sales by Application
2.5.1 Global SWFI for Reconstitution of Lyophilized Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global SWFI for Reconstitution of Lyophilized Drugs Sale Price by Application (2016-2021)

3 Global SWFI for Reconstitution of Lyophilized Drugs by Company
3.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Company
3.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Company (2019-2021)
3.1.2 Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Company (2019-2021)
3.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Company
3.2.1 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Company (2019-2021)
3.2.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Company (2019-2021)
3.3 Global SWFI for Reconstitution of Lyophilized Drugs Sale Price by Company
3.4 Global Manufacturers SWFI for Reconstitution of Lyophilized Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers SWFI for Reconstitution of Lyophilized Drugs Product Location Distribution
3.4.2 Players SWFI for Reconstitution of Lyophilized Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 SWFI for Reconstitution of Lyophilized Drugs by Region
4.1 Global SWFI for Reconstitution of Lyophilized Drugs by Region
4.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales by Region
4.1.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region
4.2 Americas SWFI for Reconstitution of Lyophilized Drugs Sales Growth
4.3 APAC SWFI for Reconstitution of Lyophilized Drugs Sales Growth
4.4 Europe SWFI for Reconstitution of Lyophilized Drugs Sales Growth
4.5 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Growth

5 Americas
5.1 Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Country
5.1.1 Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2016-2021)
5.1.2 Americas SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2021)
5.2 Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Container
5.3 Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Region
6.1.1 APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Region (2016-2021)
6.1.2 APAC SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2016-2021)
6.2 APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Container
6.3 APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe SWFI for Reconstitution of Lyophilized Drugs by Country
7.1.1 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2016-2021)
7.1.2 Europe SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2021)
7.2 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Container
7.3 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs by Country
8.1.1 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Container
8.3 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 SWFI for Reconstitution of Lyophilized Drugs Distributors
10.3 SWFI for Reconstitution of Lyophilized Drugs Customer

11 Global SWFI for Reconstitution of Lyophilized Drugs Market Forecast
11.1 Global SWFI for Reconstitution of Lyophilized Drugs Forecast by Region
11.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Forecast by Regions (2021-2026)
11.2.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global SWFI for Reconstitution of Lyophilized Drugs Forecast by Container
11.7 Global SWFI for Reconstitution of Lyophilized Drugs Forecast by Application

12 Key Players Analysis
12.1 Pfizer(Hospira)
12.1.1 Pfizer(Hospira) Company Information
12.1.2 Pfizer(Hospira) SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.1.3 Pfizer(Hospira) SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer(Hospira) Main Business Overview
12.1.5 Pfizer(Hospira) Latest Developments
12.2 B. Braun Medical Inc.
12.2.1 B. Braun Medical Inc. Company Information
12.2.2 B. Braun Medical Inc. SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.2.3 B. Braun Medical Inc. SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 B. Braun Medical Inc. Main Business Overview
12.2.5 B. Braun Medical Inc. Latest Developments
12.3 Baxter Corporation
12.3.1 Baxter Corporation Company Information
12.3.2 Baxter Corporation SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.3.3 Baxter Corporation SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Baxter Corporation Main Business Overview
12.3.5 Baxter Corporation Latest Developments
12.4 Hikma
12.4.1 Hikma Company Information
12.4.2 Hikma SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.4.3 Hikma SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Hikma Main Business Overview
12.4.5 Hikma Latest Developments
12.5 Fresenius Kabi
12.5.1 Fresenius Kabi Company Information
12.5.2 Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.5.3 Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Fresenius Kabi Main Business Overview
12.5.5 Fresenius Kabi Latest Developments
12.6 China Otsuka
12.6.1 China Otsuka Company Information
12.6.2 China Otsuka SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.6.3 China Otsuka SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 China Otsuka Main Business Overview
12.6.5 China Otsuka Latest Developments
12.7 Kelun
12.7.1 Kelun Company Information
12.7.2 Kelun SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.7.3 Kelun SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Kelun Main Business Overview
12.7.5 Kelun Latest Developments
12.8 Shijiazhuang No. 4 Pharmaceutical
12.8.1 Shijiazhuang No. 4 Pharmaceutical Company Information
12.8.2 Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.8.3 Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Shijiazhuang No. 4 Pharmaceutical Main Business Overview
12.8.5 Shijiazhuang No. 4 Pharmaceutical Latest Developments
12.9 Deo Gratias Parenteral
12.9.1 Deo Gratias Parenteral Company Information
12.9.2 Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.9.3 Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Deo Gratias Parenteral Main Business Overview
12.9.5 Deo Gratias Parenteral Latest Developments
12.10 Shapuaisi Pharma
12.10.1 Shapuaisi Pharma Company Information
12.10.2 Shapuaisi Pharma SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.10.3 Shapuaisi Pharma SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Shapuaisi Pharma Main Business Overview
12.10.5 Shapuaisi Pharma Latest Developments
12.11 Zhuhai Tongyuan Pharmaceutical
12.11.1 Zhuhai Tongyuan Pharmaceutical Company Information
12.11.2 Zhuhai Tongyuan Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.11.3 Zhuhai Tongyuan Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Zhuhai Tongyuan Pharmaceutical Main Business Overview
12.11.5 Zhuhai Tongyuan Pharmaceutical Latest Developments
12.12 Shandong Qidu Pharma Group
12.12.1 Shandong Qidu Pharma Group Company Information
12.12.2 Shandong Qidu Pharma Group SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.12.3 Shandong Qidu Pharma Group SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Shandong Qidu Pharma Group Main Business Overview
12.12.5 Shandong Qidu Pharma Group Latest Developments
12.13 Huaren
12.13.1 Huaren Company Information
12.13.2 Huaren SWFI for Reconstitution of Lyophilized Drugs Product Offered
12.13.3 Huaren SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Huaren Main Business Overview
12.13.5 Huaren Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. SWFI for Reconstitution of Lyophilized Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Vials
Table 3. Major Players of Pre-filled Syringes
Table 4. Global SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2016-2021) & (Ton)
Table 5. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2016-2021)
Table 6. Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Container (2016-2021) & ($ million)
Table 7. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Container (2016-2021)
Table 8. Global SWFI for Reconstitution of Lyophilized Drugs Sale Price by Container (2016-2021)
Table 9. Global SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2021) & (Ton)
Table 10. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2016-2021)
Table 11. Global SWFI for Reconstitution of Lyophilized Drugs Value by Application (2016-2021)
Table 12. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Application (2016-2021)
Table 13. Global SWFI for Reconstitution of Lyophilized Drugs Sale Price by Application (2016-2021)
Table 14. Global SWFI for Reconstitution of Lyophilized Drugs Sales by Company (2019-2021) & (Ton)
Table 15. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Company (2019-2021)
Table 16. Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Company (2019-2021) ($ Millions)
Table 17. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Company (2019-2021)
Table 18. Global SWFI for Reconstitution of Lyophilized Drugs Sale Price by Company (2019-2021)
Table 19. Key Manufacturers SWFI for Reconstitution of Lyophilized Drugs Producing Area Distribution and Sales Area
Table 20. Players SWFI for Reconstitution of Lyophilized Drugs Products Offered
Table 21. SWFI for Reconstitution of Lyophilized Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global SWFI for Reconstitution of Lyophilized Drugs Sales by Region (2016-2021) (Ton)
Table 25. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Region (2016-2021)
Table 26. Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Region (2016-2021)
Table 28. Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2016-2021) & (Ton)
Table 29. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Country (2016-2021)
Table 30. Americas SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Country (2016-2021)
Table 32. Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2021) & (Ton)
Table 33. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2016-2021)
Table 34. Americas SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2021) & (Ton)
Table 35. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2016-2021)
Table 36. APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Region (2016-2021) & (Ton)
Table 37. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Region (2016-2021)
Table 38. APAC SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Region (2016-2021)
Table 40. APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2016-2021) & (Ton)
Table 41. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2016-2021)
Table 42. APAC SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2021) & (Ton)
Table 43. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2016-2021)
Table 44. Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2016-2021) & (Ton)
Table 45. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Country (2016-2021)
Table 46. Europe SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Country (2016-2021)
Table 48. Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2021) & (Ton)
Table 49. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2016-2021)
Table 50. Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2021) & (Ton)
Table 51. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Country (2016-2021) & (Ton)
Table 53. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Container (2016-2021) & (Ton)
Table 57. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container (2016-2021)
Table 58. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2021) & (Ton)
Table 59. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of SWFI for Reconstitution of Lyophilized Drugs
Table 61. Key Application and Potential Industries of SWFI for Reconstitution of Lyophilized Drugs
Table 62. Key Challenges of SWFI for Reconstitution of Lyophilized Drugs
Table 63. Key Trends of SWFI for Reconstitution of Lyophilized Drugs
Table 64. SWFI for Reconstitution of Lyophilized Drugs Distributors List
Table 65. SWFI for Reconstitution of Lyophilized Drugs Customer List
Table 66. Global SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Region (2021-2026) & (Ton)
Table 67. Global SWFI for Reconstitution of Lyophilized Drugs Consumption Market Forecast by Region
Table 68. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Country (2021-2026) & (Ton)
Table 71. Americas SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Region (2021-2026) & (Ton)
Table 73. APAC SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Country (2021-2026) & (Ton)
Table 75. Europe SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Country (2021-2026) & (Ton)
Table 77. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Container (2021-2026) & (Ton)
Table 79. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share Forecast by Container (2021-2026)
Table 80. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Container (2021-2026) & ($ Millions)
Table 81. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share Forecast by Container (2021-2026)
Table 82. Global SWFI for Reconstitution of Lyophilized Drugs Sales Forecast by Application (2021-2026) & (Ton)
Table 83. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share Forecast by Application (2021-2026)
Table 84. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 86. Pfizer(Hospira) Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer(Hospira) SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 88. Pfizer(Hospira) SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 89. Pfizer(Hospira) Main Business
Table 90. Pfizer(Hospira) Latest Developments
Table 91. B. Braun Medical Inc. Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. B. Braun Medical Inc. SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 93. B. Braun Medical Inc. SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 94. B. Braun Medical Inc. Main Business
Table 95. B. Braun Medical Inc. Latest Developments
Table 96. Baxter Corporation Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Baxter Corporation SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 98. Baxter Corporation SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 99. Baxter Corporation Main Business
Table 100. Baxter Corporation Latest Developments
Table 101. Hikma Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Hikma SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 103. Hikma SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 104. Hikma Main Business
Table 105. Hikma Latest Developments
Table 106. Fresenius Kabi Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 108. Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 109. Fresenius Kabi Main Business
Table 110. Fresenius Kabi Latest Developments
Table 111. China Otsuka Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. China Otsuka SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 113. China Otsuka SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 114. China Otsuka Main Business
Table 115. China Otsuka Latest Developments
Table 116. Kelun Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Kelun SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 118. Kelun SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 119. Kelun Main Business
Table 120. Kelun Latest Developments
Table 121. Shijiazhuang No. 4 Pharmaceutical Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 123. Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 124. Shijiazhuang No. 4 Pharmaceutical Main Business
Table 125. Shijiazhuang No. 4 Pharmaceutical Latest Developments
Table 126. Deo Gratias Parenteral Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 128. Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 129. Deo Gratias Parenteral Main Business
Table 130. Deo Gratias Parenteral Latest Developments
Table 131. Shapuaisi Pharma Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Shapuaisi Pharma SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 133. Shapuaisi Pharma SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 134. Shapuaisi Pharma Main Business
Table 135. Shapuaisi Pharma Latest Developments
Table 136. Zhuhai Tongyuan Pharmaceutical Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Zhuhai Tongyuan Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 138. Zhuhai Tongyuan Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 139. Zhuhai Tongyuan Pharmaceutical Main Business
Table 140. Zhuhai Tongyuan Pharmaceutical Latest Developments
Table 141. Shandong Qidu Pharma Group Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Shandong Qidu Pharma Group SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 143. Shandong Qidu Pharma Group SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 144. Shandong Qidu Pharma Group Main Business
Table 145. Shandong Qidu Pharma Group Latest Developments
Table 146. Huaren Basic Information, SWFI for Reconstitution of Lyophilized Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Huaren SWFI for Reconstitution of Lyophilized Drugs Product Offered
Table 148. Huaren SWFI for Reconstitution of Lyophilized Drugs Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 149. Huaren Main Business
Table 150. Huaren Latest Developments
List of Figures
Figure 1. Picture of SWFI for Reconstitution of Lyophilized Drugs
Figure 2. SWFI for Reconstitution of Lyophilized Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global SWFI for Reconstitution of Lyophilized Drugs Sales Growth Rate 2016-2026 (Ton)
Figure 7. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. SWFI for Reconstitution of Lyophilized Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Vials
Figure 10. Product Picture of Pre-filled Syringes
Figure 11. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container in 2020
Figure 12. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Container (2016-2021)
Figure 13. SWFI for Reconstitution of Lyophilized Drugs Consumed in Hospitals
Figure 14. Global SWFI for Reconstitution of Lyophilized Drugs Market: Hospitals (2016-2021) & (Ton)
Figure 15. SWFI for Reconstitution of Lyophilized Drugs Consumed in Clinics
Figure 16. Global SWFI for Reconstitution of Lyophilized Drugs Market: Clinics (2016-2021) & (Ton)
Figure 17. SWFI for Reconstitution of Lyophilized Drugs Consumed in Others
Figure 18. Global SWFI for Reconstitution of Lyophilized Drugs Market: Others (2016-2021) & (Ton)
Figure 19. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application (2016-2021)
Figure 20. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Application in 2020
Figure 21. SWFI for Reconstitution of Lyophilized Drugs Revenue Market by Company in 2020 ($ Million)
Figure 22. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Company in 2020
Figure 23. Global SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Regions (2016-2021)
Figure 24. Global SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Region in 2020
Figure 25. Americas SWFI for Reconstitution of Lyophilized Drugs Sales 2016-2021 (Ton)
Figure 26. Americas SWFI for Reconstitution of Lyophilized Drugs Revenue 2016-2021 ($ Millions)
Figure 27. APAC SWFI for Reconstitution of Lyophilized Drugs Sales 2016-2021 (Ton)
Figure 28. APAC SWFI for Reconstitution of Lyophilized Drugs Revenue 2016-2021 ($ Millions)
Figure 29. Europe SWFI for Reconstitution of Lyophilized Drugs Sales 2016-2021 (Ton)
Figure 30. Europe SWFI for Reconstitution of Lyophilized Drugs Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales 2016-2021 (Ton)
Figure 32. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue 2016-2021 ($ Millions)
Figure 33. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Country in 2020
Figure 34. Americas SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Country in 2020
Figure 35. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container in 2020
Figure 36. Americas SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application in 2020
Figure 37. United States SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Region in 2020
Figure 42. APAC SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Regions in 2020
Figure 43. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container in 2020
Figure 44. APAC SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application in 2020
Figure 45. China SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. India SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Country in 2020
Figure 52. Europe SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Country in 2020
Figure 53. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container in 2020
Figure 54. Europe SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application in 2020
Figure 55. Germany SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. France SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Country in 2020
Figure 61. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Container in 2020
Figure 63. Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales Market Share by Application in 2020
Figure 64. Egypt SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country SWFI for Reconstitution of Lyophilized Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


★調査レポート[世界の凍結乾燥薬再構成用SWFI市場予測 2021年-2026年] (コード：LPI21MY9667)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の凍結乾燥薬再構成用SWFI市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の注射用滅菌水（SWFI）市場予測 2021年-2026年
    LPI21MY9658 / LP Information / 2021年5月 / LPインフォメーション社の「注射用滅菌水（SWFI）の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、バイアル、ガラス瓶、プレフィルドシリンジなど、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。注射用滅菌水（SWFI）のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用滅菌水（SWFI）の世界市場概要（サマリー） ・注射用滅菌水（SWFI）の企業別販売量・売上 ・注射用滅菌水（SWFI）の企業別市場シェア ・注射用滅菌水（SWFI）の世界市場規模 2016年-2021年：種類別（バイアル、ガラス瓶、プレフィルドシリンジ） ・注射用滅菌水（SWFI）の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・注射用滅菌水（SWFI）の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・注射用滅菌水（SWFI）のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Sterile Water for Injection (SWFI) will have significant change from previous year. By the most conservative estimates of global Sterile Water for Injection (SWFI) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Sterile Water for Injection (SWFI) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Sterile...
  • 世界の点眼薬市場予測 2021年-2026年
    LPI21MY9609 / LP Information / 2021年5月 / LPインフォメーション社の「点眼薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬など、用途別には、緑内障、ドライアイ症候群、網膜疾患、その他などにセグメント区分してまとめました。点眼薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・点眼薬の世界市場概要（サマリー） ・点眼薬の企業別販売量・売上 ・点眼薬の企業別市場シェア ・点眼薬の世界市場規模 2016年-2021年：種類別（網膜障害治療薬、アレルギー治療薬、炎症治療薬、感染治療薬、緑内障治療薬、ドライアイ治療薬） ・点眼薬の世界市場規模 2016年-2021年：用途別（緑内障、ドライアイ症候群、網膜疾患、その他） ・点眼薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・点眼薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Ophthalmol Drugs will have significant change from previous year. By the most conservative estimates of global Ophthalmol Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Ophthalmol Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmol Drugs market by product type, application, key manufacturers and...
  • 世界の抗糖尿病薬市場予測 2021年-2026年
    LPI21MY9415 / LP Information / 2021年5月 / LPインフォメーション社の「抗糖尿病薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口薬、注射薬など、用途別には、1型糖尿病、2型糖尿病、妊娠糖尿病、その他などにセグメント区分してまとめました。抗糖尿病薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・抗糖尿病薬の世界市場概要（サマリー） ・抗糖尿病薬の企業別販売量・売上 ・抗糖尿病薬の企業別市場シェア ・抗糖尿病薬の世界市場規模 2016年-2021年：種類別（経口薬、注射薬） ・抗糖尿病薬の世界市場規模 2016年-2021年：用途別（1型糖尿病、2型糖尿病、妊娠糖尿病、その他） ・抗糖尿病薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・抗糖尿病薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Antidiabetic Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Antidiabetic Drugs market by product type, application, key manufacturers and...
  • 世界のオキシコドン塩酸塩治療薬市場予測 2021年-2026年
    LPI21MY9614 / LP Information / 2021年5月 / LPインフォメーション社の「オキシコドン塩酸塩治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、錠剤、経口液剤、経口カプセル、静脈内輸液など、用途別には、病院、診療所、その他などにセグメント区分してまとめました。オキシコドン塩酸塩治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・オキシコドン塩酸塩治療薬の世界市場概要（サマリー） ・オキシコドン塩酸塩治療薬の企業別販売量・売上 ・オキシコドン塩酸塩治療薬の企業別市場シェア ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：種類別（錠剤、経口液剤、経口カプセル、静脈内輸液） ・オキシコドン塩酸塩治療薬の世界市場規模 2016年-2021年：用途別（病院、診療所、その他） ・オキシコドン塩酸塩治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・オキシコドン塩酸塩治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Oxycodone Hydrochloride Drugs will have significant change from previous year. By the most conservative estimates of global Oxycodone Hydrochloride Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Oxycodone Hydrochloride Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Oxycodone Hydrochloride Drugs market by product type,...
  • 世界の神経内分泌がん治療薬市場予測 2021年-2026年
    LPI21MY9603 / LP Information / 2021年5月 / LPインフォメーション社の「神経内分泌がん治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ソマトスタチン類似体、標的療法、化学療法など、用途別には、病院、クリニック、腫瘍学センター、外来手術センターなどにセグメント区分してまとめました。神経内分泌がん治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・神経内分泌がん治療薬の世界市場概要（サマリー） ・神経内分泌がん治療薬の企業別販売量・売上 ・神経内分泌がん治療薬の企業別市場シェア ・神経内分泌がん治療薬の世界市場規模 2016年-2021年：種類別（ソマトスタチン類似体、標的療法、化学療法） ・神経内分泌がん治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、腫瘍学センター、外来手術センター） ・神経内分泌がん治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・神経内分泌がん治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Neuroendocrine Carcinoma Drugs will have significant change from previous year. By the most conservative estimates of global Neuroendocrine Carcinoma Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Neuroendocrine Carcinoma Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Neuroendocrine Carcinoma Drugs market by product type,...
  • 世界の精神障害治療薬市場予測 2021年-2026年
    LPI21MY9588 / LP Information / 2021年5月 / LPインフォメーション社の「精神障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質＆アルコール中毒治療薬、小児期＆青年期精神障害薬、認知障害治療薬、睡眠障害、その他など、用途別には、子供、青年、大人などにセグメント区分してまとめました。精神障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・精神障害治療薬の世界市場概要（サマリー） ・精神障害治療薬の企業別販売量・売上 ・精神障害治療薬の企業別市場シェア ・精神障害治療薬の世界市場規模 2016年-2021年：種類別（統合失調症薬、抗うつ薬、抗精神病薬、抗不安薬、物質＆アルコール中毒治療薬、小児期＆青年期精神障害薬、認知障害治療薬、睡眠障害、その他） ・精神障害治療薬の世界市場規模 2016年-2021年：用途別（子供、青年、大人） ・精神障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・精神障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mental Disorders Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Mental Disorders Drugs market by product type,...
  • 世界のCD38モノクローナル抗体薬市場予測 2021年-2026年
    LPI21MY9468 / LP Information / 2021年5月 / LPインフォメーション社の「CD38モノクローナル抗体薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ダレツズマブ、イサルツキシマブ、人工毒素体など、用途別には、多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他などにセグメント区分してまとめました。CD38モノクローナル抗体薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・CD38モノクローナル抗体薬の世界市場概要（サマリー） ・CD38モノクローナル抗体薬の企業別販売量・売上 ・CD38モノクローナル抗体薬の企業別市場シェア ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：種類別（ダレツズマブ、イサルツキシマブ、人工毒素体） ・CD38モノクローナル抗体薬の世界市場規模 2016年-2021年：用途別（多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、その他） ・CD38モノクローナル抗体薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・CD38モノクローナル抗体薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of CD38 Monoclonal Antibody Drugs will have significant change from previous year. By the most conservative estimates of global CD38 Monoclonal Antibody Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the CD38 Monoclonal Antibody Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of CD38 Monoclonal Antibody Drugs...
  • 世界の自己投与薬市場予測 2021年-2026年
    LPI21MY9572 / LP Information / 2021年5月 / LPインフォメーション社の「自己投与薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射薬、吸入薬、経皮吸収薬など、用途別には、心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他などにセグメント区分してまとめました。自己投与薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・自己投与薬の世界市場概要（サマリー） ・自己投与薬の企業別販売量・売上 ・自己投与薬の企業別市場シェア ・自己投与薬の世界市場規模 2016年-2021年：種類別（注射薬、吸入薬、経皮吸収薬） ・自己投与薬の世界市場規模 2016年-2021年：用途別（心血管疾患、糖尿病、骨粗鬆症、疼痛管理、ホルモン補充療法、その他） ・自己投与薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・自己投与薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Self-administered Drugs will have significant change from previous year. By the most conservative estimates of global Self-administered Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Self-administered Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Self-administered Drugs market by product type, application, key manufacturers and...
  • 世界のジョサマイシン薬市場予測 2021年-2026年
    LPI21MY9651 / LP Information / 2021年5月 / LPインフォメーション社の「ジョサマイシン薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒など、用途別には、病院薬局、小売ドラッグストアなどにセグメント区分してまとめました。ジョサマイシン薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ジョサマイシン薬の世界市場概要（サマリー） ・ジョサマイシン薬の企業別販売量・売上 ・ジョサマイシン薬の企業別市場シェア ・ジョサマイシン薬の世界市場規模 2016年-2021年：種類別（ジョサマイシン錠、ジョサマイシンプロピオン酸顆粒） ・ジョサマイシン薬の世界市場規模 2016年-2021年：用途別（病院薬局、小売ドラッグストア） ・ジョサマイシン薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ジョサマイシン薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Josamycin Drugs will have significant change from previous year. By the most conservative estimates of global Josamycin Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Josamycin Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Josamycin Drugs market by product type, application, key manufacturers and...
  • 世界の双極性障害治療薬市場予測 2021年-2026年
    LPI21MY9449 / LP Information / 2021年5月 / LPインフォメーション社の「双極性障害治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、気分安定薬、抗精神病薬、抗うつ薬、その他薬品など、用途別には、病院、研究室、その他などにセグメント区分してまとめました。双極性障害治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・双極性障害治療薬の世界市場概要（サマリー） ・双極性障害治療薬の企業別販売量・売上 ・双極性障害治療薬の企業別市場シェア ・双極性障害治療薬の世界市場規模 2016年-2021年：種類別（気分安定薬、抗精神病薬、抗うつ薬、その他薬品） ・双極性障害治療薬の世界市場規模 2016年-2021年：用途別（病院、研究室、その他） ・双極性障害治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・双極性障害治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Bipolar Disorder Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorder Drugs market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆